Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCRP8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,802
Award facts
- Contract value 100% obligated
- $11,802.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,802.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 unit vials. The contract, awarded on December 12, 2025, with an ultimate completion date of January 6, 2026, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded in November 2025 that positions the company as a regional prime vendor for pharmaceutical supplies supporting Department of Defense healthcare operations globally.
The PPV-G GEN V represents a critical component of the broader $30.3 billion pharmaceutical acquisition strategy designed to ensure reliable supply of branded and generic prescription medications, biologics, over-the-counter drugs, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders across diverse therapeutic categories demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system. The company maintains no identified subcontractor relationships and operates as the sole awardee on this delivery order, reinforcing its direct supplier relationship with the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FCRP8?
SPE2DR26FCRP8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FCRP8 worth?
The government has obligated $11,802 on SPE2DR26FCRP8.
Is contract SPE2DR26FCRP8 an order under another contract?
Yes. SPE2DR26FCRP8 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRP8 competed?
The extent of competition for SPE2DR26FCRP8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award